サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1411304

臨床試験用品市場：フェーズ、タイプ、製品、治療分野、エンドユーザー別 2024～2030年の世界予測

Clinical Trial Supplies Market by Phase (Phase 1, Phase 2, Phase 3), Type (Biologic Drugs, Medical Devices, Small-Molecules), Product, Therapeutic Area, End User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 187 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
臨床試験用品市場：フェーズ、タイプ、製品、治療分野、エンドユーザー別 2024～2030年の世界予測
出版日: 2024年01月09日
発行: 360iResearch
ページ情報: 英文 187 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床試験用品市場規模は2023年に33億5,000万米ドルと推計され、2024年には36億4,000万米ドルに達し、CAGR 8.43%で2030年には59億2,000万米ドルに達すると予測されます。

臨床試験用品の世界市場

主な市場の統計
基準年[2023］ 33億5,000万米ドル
予測年[2024］ 36億4,000万米ドル
予測年 [2030] 59億2,000万米ドル
CAGR（%） 8.43%
臨床試験用品 Market-IMG1

臨床試験用品は、臨床研究の基本的かつ複雑な構成要素であり、最終的には治療法のブレークスルーを成功させ、患者の治療経路を画期的に改善する道を開くのに役立ちます。これらの医薬品は、前臨床試験から市販後調査までの様々な研究段階に対応し、臨床試験のシームレスな管理と実施を促進します。感染症や慢性疾患の世界の流行と、それに伴う製薬・バイオ医薬品業界の研究開発費を伴う臨床試験の増加は、市場の成長を刺激します。臨床試験用品に関連する高コスト、供給に関する厳しい規制、国境を越えたロジスティクスの課題は、市場の成長を制限します。医薬品開発への重点化と患者中心の臨床試験へのシフトは、臨床試験患者の募集、試験登録、参加者維持の改善につながる可能性があります。また、多様な臨床試験用品の進歩により、製薬・バイオ医薬品企業にとって新たな研究の道が開けると期待されています。

地域別の洞察

米国とカナダを中心とする南北アメリカでは、慢性疾患の診断率が高く、ヘルスケアインフラがしっかりしているため、臨床試験用品への依存度が高いです。過去1年間に登録された主な特許は、サプライチェーンモデルの最適化と、試験供給と需要を一致させるための高度なアナリティクスの採用に関連するものでした。欧州連合（EU）、中東・アフリカでは、ヘルスケアへのアクセスや支出に格差があるため、多様なニーズが見られます。欧州では、研究開発への重点的な投資と高齢者人口の急増に後押しされ、臨床試験用品に対する需要が安定しています。これとは対照的に、中東やアフリカ諸国は新興市場であり、研究活動は活発であるが、資金やインフラが限られているため、その動きは鈍いです。中国、日本、インドを含むアジア太平洋地域は、医療インフラ整備への多額の投資により、高い疾患罹患率が報告されています。製薬業界の活況がこれらの地域の臨床試験用品市場を牽引しており、その需要はスピードよりも費用対効果に左右されます。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは臨床試験用品市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、臨床試験用品市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-臨床試験用品市場の市場規模および予測は？

2-臨床試験用品市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-臨床試験用品市場における技術動向と規制の枠組みは？

4-臨床試験用品市場における主要ベンダーの市場シェアは？

5-臨床試験用品市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で感染症や慢性疾患の蔓延が増加
      • 製薬およびバイオ医薬品業界による研究開発支出の増加
    • 抑制要因
      • 臨床試験用品のコストが高い
    • 機会
      • 医薬品開発の重視と患者中心の臨床試験への移行
      • 多様な臨床試験用品における継続的な進歩
    • 課題
      • 臨床試験用品に対する厳しい規制
  • 市場セグメンテーション分析
    • フェーズ：臨床試験に関する最適な意思決定のため、フェーズごとに臨床試験用品の需要が増加
    • タイプ：慢性疾患の画期的な治療法による生物学的製剤の需要の急増
    • 製品：補助医薬品は、安全性を確保し、調査全体の効率を確保する重要性があるため、臨床試験の重要な要素です。
    • 治療分野：世界中で感染症の負担が増大しているため、臨床試験用品の需要が生じています
    • エンドユーザー：研究開発活動のアウトソーシングの増加により、CROでの臨床試験用品の使用が増加
  • 市場動向分析
    • 老舗製薬会社は臨床試験の数を増やすことに重点を置いており、南北アメリカで臨床試験用品の必要性の高まり
    • APAC地域における規制や基準を支援するとともに、臨床試験能力を強化するための政府の取り組みを拡大する
    • EMEAにおける臨床試験数の増加と強力かつ先進的な医薬品セクター
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 臨床試験用品市場フェーズ別

  • フェーズI
  • フェーズ II
  • フェーズⅢ
  • フェーズ IV

第7章 臨床試験用品市場：タイプ別

  • 生物学的製剤
  • 医療機器
  • 低分子

第8章 臨床試験用品市場：製品別

  • 補助医薬品
  • インタラクティブ応答テクノロジー（IRT）ソリューション
  • 実験用品
    • 遠心分離機
    • 顕微鏡
    • ピペット
    • 試薬
  • 医療機器と診断
  • 薬局用品
    • バイオハザードバッグ
    • 配合無菌アイソレータ
    • 滅菌装置
  • 調査資料
  • 安全装置

第9章 臨床試験用品市場治療領域別

  • 心臓病学
  • 遺伝病
  • 免疫学
  • 感染症
  • 代謝障害
  • 神経内科
  • 腫瘍学

第10章 臨床試験用品市場：エンドユーザー別

  • 受託調査機関
  • 製薬およびバイオテクノロジー企業

第11章 南北アメリカの臨床試験用品市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋地域の臨床試験用品市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第13章 欧州・中東・アフリカの臨床試験用品市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析
    • 合併・買収
    • 契約、コラボレーション、パートナーシップ
    • 新製品発売と機能強化
    • 投資、資金調達
    • 受賞・表彰・拡大

第15章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • 3M Company
    • Abbott Laboratories
    • Almac Group Limited
    • B. Braun SE
    • Baxter International, Inc.
    • Bayer AG
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Bruker Corporation
    • Cardinal Health, Inc.
    • Charles River Laboratories, Inc.
    • COREX LOGISTICS LIMITED
    • Emsere B.V by Medicapital Holdco B.V.
    • Eppendorf SE
    • Evident Corporation by Olympus Corporation
    • F. Hoffmann-La Roche Ltd.
    • Fujifilm Group
    • Hipro Biotechnology Co., Ltd.
    • Hitachi, Ltd.
    • HORIBA, Ltd.
    • ICON PLC
    • Immudex ApS
    • Incyte Corporation
    • IQVIA Inc.
    • Johnson & Johnson Services, Inc.
    • KLIFO A/S
    • Labnet International
    • Leica Microsystems GmbH by Danaher Corporation
    • llumina, Inc.
    • Lonza Group Ltd.
    • Medline Industries, LP
    • Merck KGaA
    • Myonex, LLC
    • Novo Nordisk A/S
    • Nuvisan GmbH
    • Parexel International Corporation
    • Perceptive Informatics LLC and its affiliates, d/b/a Calyx
    • PerkinElmer Inc. by Revvity, Inc.
    • Pfizer Inc.
    • Promega Corporation
    • Recipharm AB
    • Rubicon Research Pvt. Ltd.
    • Sekisui Diagnostics Group
    • Sharp Services, LLC
    • Siemens Healthcare GmbH
    • Smith & Nephew PLC
    • Stryker Corporation
    • Thermo Fisher Scientific Inc.
    • Woodley Equipment Company Ltd.
  • 主要な製品ポートフォリオ

第16章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL SUPPLIES MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIAL SUPPLIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. CLINICAL TRIAL SUPPLIES MARKET SIZE, 2019-2030 (USD MILLION)
  • FIGURE 4. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CLINICAL TRIAL SUPPLIES MARKET DYNAMICS
  • FIGURE 7. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 8. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 12. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 14. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 16. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. CLINICAL TRIAL SUPPLIES MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 26. CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL SUPPLIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2019-2023
  • TABLE 3. CLINICAL TRIAL SUPPLIES MARKET SIZE, 2019-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 5. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 6. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE I, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 7. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE II, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 8. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE III, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 9. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE IV, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 10. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 11. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 12. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 13. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SMALL-MOLECULES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 14. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 15. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY AUXILIARY MEDICINAL PRODUCTS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 16. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INTERACTIVE RESPONSE TECHNOLOGY (IRT) SOLUTIONS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 17. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 18. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 19. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 20. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MICROSCOPES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 21. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PIPETTES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 22. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REAGENTS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 23. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES & DIAGNOSTICS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 24. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 25. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 26. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOHAZARD BAGS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 27. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COMPOUNDING ASEPTIC ISOLATORS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 28. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 29. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY RESEARCH MATERIALS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 30. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SAFETY EQUIPMENT, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 31. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 32. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 33. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY GENETIC DISEASES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 34. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 35. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 36. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 37. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NEUROLOGY, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 38. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 39. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 40. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 41. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 42. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 43. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 44. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 45. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 46. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 47. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 48. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 49. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 50. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 52. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 54. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 57. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 58. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 59. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 60. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 61. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 62. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 63. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 64. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 65. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 66. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 67. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 68. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 69. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 70. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 71. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 72. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 73. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 74. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 75. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 76. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 77. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 78. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 79. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 80. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 81. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 82. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 83. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 84. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 85. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2019-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 101. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 102. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 103. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 104. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 105. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 106. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 107. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 108. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 109. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 110. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 111. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 112. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 113. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 114. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 115. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 116. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 117. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 118. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 119. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 120. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 121. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 122. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 123. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 124. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 125. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 126. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 127. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 128. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 129. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 130. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 131. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 132. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 133. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 134. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 135. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 142. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 143. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 144. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 145. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 146. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 147. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 148. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 149. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 156. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 157. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 158. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 159. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 160. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 161. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 162. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 163. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 164. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 165. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 166. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 167. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 168. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 169. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 170. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 171. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 172. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 173. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 174. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 175. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 176. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 177. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 186. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 187. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 188. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 189. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 190. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 191. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 192. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 193. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 194. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 195. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 196. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 197. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 198. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 199. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 200. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 201. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 202. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 203. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 204. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 205. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 206. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 207. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 208. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 209. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 210. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 211. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 212. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 213. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 214. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 215. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 216. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 217. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 218. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 219. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 220. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 221. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 222. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 223. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 224. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 225. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 226. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 227. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 228. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 229. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 230. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 231. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 232. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 233. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 234. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 241. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 242. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 243. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 244. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 245. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 246. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 247. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 248. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 249. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 250. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 251. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 252. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 253. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 254. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 255. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 256. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 257. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 258. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 259. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 260. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 261. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 262. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 263. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 264. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 265. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 266. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 267. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 268. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 269. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 270. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 271. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 272. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 273. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 274. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 275. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 276. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 283. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 290. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 291. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 292. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 293. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 294. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 295. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 296. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 297. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 298. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 299. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 300. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 301. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 302. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 303. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 304. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 310. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 311. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 312. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 313. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 314. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 315. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 316. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 317. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 318. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 322. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 324. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 325. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 329. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 330. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 331. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 332. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 333. CLINICAL TRIAL SUPPLIES MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 334. CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 335. CLINICAL TRIAL SUPPLIES MARKET LICENSE & PRICING
目次
Product Code: MRR-E0619F076722

[187 Pages Report] The Clinical Trial Supplies Market size was estimated at USD 3.35 billion in 2023 and expected to reach USD 3.64 billion in 2024, at a CAGR 8.43% to reach USD 5.92 billion by 2030.

Global Clinical Trial Supplies Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.35 billion
Estimated Year [2024] USD 3.64 billion
Forecast Year [2030] USD 5.92 billion
CAGR (%) 8.43%
Clinical Trial Supplies Market - IMG1

Clinical trial supplies are a fundamental yet complex component of clinical research, ultimately helping pave the way toward successful therapeutic breakthroughs and monumental enhancements in patient care pathways. These supplies cater to various research phases, from pre-clinical examinations to post-marketing surveillance studies, thus facilitating the seamless management and execution of clinical investigations. The increasing prevalence of infectious and chronic diseases worldwide and the subsequent rise in clinical trials with research and development expenditure of the pharmaceutical and biopharmaceutical industry stimulates market growth. The high cost associated with clinical trial supplies, stringent regulations for supplies, and cross-border logistics challenges restrict market growth. Growing emphasis on drug development and shifting towards patient-centric clinical trials offer the potential for better clinical trial patient recruitment, study enrollment, and participant retention. In addition, ongoing advancements in a diverse range of clinical trial supplies are expected to open new research avenues for pharmaceutical and biopharmaceutical companies.

Regional Insights

In the Americas, primarily the United States and Canada, there is a significant dependence on clinical trial supplies due to a high diagnosis rate of chronic diseases and robust healthcare infrastructure. Over the past year, the major patents registered revolved around optimizing supply chain models and employing advanced analytics to align trial supply with demand. The European Union (EU), the Middle East, and Africa exhibit a diverse range of needs due to discrepancies in healthcare access and spending. Europe witnesses steady demand for clinical trial supplies, fueled by heavy investments in research and development initiatives and a surge in the geriatric population. In contrast, Middle Eastern and African countries encompass emerging markets with rising research activities yet laid back due to limited funding and infrastructural impediments. Asia-Pacific, including China, Japan, and India, reports a high disease prevalence, bridged by substantial investments in improving healthcare infrastructure. The booming pharmaceutical industry drives the clinical trial supplies market in these regions, and the demand is dictated more by cost-efficacy rather than speed, mirroring their unique healthcare economic dynamics.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Trial Supplies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Trial Supplies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supplies Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Almac Group Limited, B. Braun SE, Baxter International, Inc., Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bruker Corporation, Cardinal Health, Inc., Charles River Laboratories, Inc., COREX LOGISTICS LIMITED, Emsere B.V by Medicapital Holdco B.V., Eppendorf SE, Evident Corporation by Olympus Corporation, F. Hoffmann-La Roche Ltd., Fujifilm Group, Hipro Biotechnology Co., Ltd., Hitachi, Ltd., HORIBA, Ltd., ICON PLC, Immudex ApS, Incyte Corporation, IQVIA Inc., Johnson & Johnson Services, Inc., KLIFO A/S, Labnet International, Leica Microsystems GmbH by Danaher Corporation, llumina, Inc., Lonza Group Ltd., Medline Industries, LP, Merck KGaA, Myonex, LLC, Novo Nordisk A/S, Nuvisan GmbH, Parexel International Corporation, Perceptive Informatics LLC and its affiliates, d/b/a Calyx, PerkinElmer Inc. by Revvity, Inc., Pfizer Inc., Promega Corporation, Recipharm AB, Rubicon Research Pvt. Ltd., Sekisui Diagnostics Group, Sharp Services, LLC, Siemens Healthcare GmbH, Smith & Nephew PLC, Stryker Corporation, Thermo Fisher Scientific Inc., and Woodley Equipment Company Ltd..

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Supplies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Phase
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Type Biologic Drugs
    • Medical Devices
    • Small-Molecules
  • Product
    • Auxiliary Medicinal Products
    • Interactive Response Technology (IRT) solutions
    • Lab Supplies
      • Centrifuges
      • Microscopes
      • Pipettes
      • Reagents
    • Medical Devices & Diagnostics
    • Pharmacy Supplies
      • Biohazard Bags
      • Compounding Aseptic Isolators
      • Sterilization Equipment
    • Research Materials
    • Safety Equipment
  • Therapeutic Area
    • Cardiology
    • Genetic Diseases
    • Immunology
    • Infectious Diseases
    • Metabolic Disorders
    • Neurology
    • Oncology
  • End User
    • Contract Research Organisations
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Clinical Trial Supplies Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Trial Supplies Market?

3. What are the technology trends and regulatory frameworks in the Clinical Trial Supplies Market?

4. What is the market share of the leading vendors in the Clinical Trial Supplies Market?

5. Which modes and strategic moves are suitable for entering the Clinical Trial Supplies Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Clinical Trial Supplies Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of infectious and chronic diseases worldwide
      • 5.1.1.2. Rising research and development expenditure by pharmaceutical and biopharmaceutical industry
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of clinical trial supplies
    • 5.1.3. Opportunities
      • 5.1.3.1. Emphasis on drug development and shift towards patient-centric clinical trials
      • 5.1.3.2. Ongoing advancements in a diverse range of clinical trial supplies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations for clinical trial supplies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Phase: Growing demand for clinical trial supplies for each phase for optimal decision-making regarding clinical trial
    • 5.2.2. Type: Surge in biologic drugs demand with breakthrough therapies for chronic ailments
    • 5.2.3. Product: Auxiliary medicinal products are vital elements of clinical trials, owing to their significance of assuring safety, and efficiency in the overall research operation
    • 5.2.4. Therapeutic Area: Rising burden of infectious diseases worldwide create a demand for clinical trial supplies
    • 5.2.5. End User: Growing use of clinical trial supplies in CROs due to rising outsourcing of R&D activities
  • 5.3. Market Trend Analysis
    • 5.3.1. Well-established pharmaceutical companies emphasis on increasing the number of clinical trials, propelling the need for clinical trial supplies in the Americas
    • 5.3.2. Expanding government initiatives to strengthen the clinical trial capabilities coupled with supportive regulations and standards in the APAC region
    • 5.3.3. Increasing number of clinical trials and strong and advanced pharmaceutical sector in the EMEA
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Clinical Trial Supplies Market, by Phase

  • 6.1. Introduction
  • 6.2. Phase I
  • 6.3. Phase II
  • 6.4. Phase III
  • 6.5. Phase IV

7. Clinical Trial Supplies Market, by Type

  • 7.1. Introduction
  • 7.2. Biologic Drugs
  • 7.3. Medical Devices
  • 7.4. Small-Molecules

8. Clinical Trial Supplies Market, by Product

  • 8.1. Introduction
  • 8.2. Auxiliary Medicinal Products
  • 8.3. Interactive Response Technology (IRT) solutions
  • 8.4. Lab Supplies
    • 8.5.1. Centrifuges
    • 8.5.2. Microscopes
    • 8.5.3. Pipettes
    • 8.5.4. Reagents
  • 8.5. Medical Devices & Diagnostics
  • 8.6. Pharmacy Supplies
    • 8.7.1. Biohazard Bags
    • 8.7.2. Compounding Aseptic Isolators
    • 8.7.3. Sterilization Equipment
  • 8.7. Research Materials
  • 8.8. Safety Equipment

9. Clinical Trial Supplies Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Cardiology
  • 9.3. Genetic Diseases
  • 9.4. Immunology
  • 9.5. Infectious Diseases
  • 9.6. Metabolic Disorders
  • 9.7. Neurology
  • 9.8. Oncology

10. Clinical Trial Supplies Market, by End User

  • 10.1. Introduction
  • 10.2. Contract Research Organisations
  • 10.3. Pharmaceutical & Biotechnology Companies

11. Americas Clinical Trial Supplies Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Clinical Trial Supplies Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Supplies Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player
    • 14.3.1. Merger & Acquisition
      • 14.3.1.1. Signal: UK Clinical Research Provider Ergomed Bought Out in USD 888 Million Deal
      • 14.3.1.2. Sitero Acquires Clario's eClinical Technology Suite to Enhance Clinical Trial Delivery
      • 14.3.1.3. Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
    • 14.3.2. Agreement, Collaboration, & Partnership
      • 14.3.2.1. Loftware and Tenthpin Collaborate on Clinical Supply Labeling
      • 14.3.2.2. Replimune and Incyte Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280 in Patients with Cutaneous Squamous Cell Carcinoma
      • 14.3.2.3. IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer to Support Registrational Trial Evaluating Darovasertib and Crizotinib Combination in First-Line Metastatic Uveal Melanoma
      • 14.3.2.4. Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions to Meet Increase in Investigational Drug Demand for Ongoing and Planned Clinical Trials
    • 14.3.3. New Product Launch & Enhancement
      • 14.3.3.1. Thermo Fisher Scientific Launches New Smart Refrigerator Series
      • 14.3.3.2. BD Launches New Robotic System to Automate Clinical Flow Cytometry
    • 14.3.4. Investment & Funding
      • 14.3.4.1. Experic Closes USD 14 Million Series B Financing
      • 14.3.4.2. Medline Invests Additional USD 500M in Medical Supply Inventory to Boost Product Availability
    • 14.3.5. Award, Recognition, & Expansion
      • 14.3.5.1. Siemens Healthineers Launch Laboratory Equipment R&D Centre in Swords

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. 3M Company
    • 15.1.2. Abbott Laboratories
    • 15.1.3. Almac Group Limited
    • 15.1.4. B. Braun SE
    • 15.1.5. Baxter International, Inc.
    • 15.1.6. Bayer AG
    • 15.1.7. Becton, Dickinson and Company
    • 15.1.8. Bio-Rad Laboratories, Inc.
    • 15.1.9. Bruker Corporation
    • 15.1.10. Cardinal Health, Inc.
    • 15.1.11. Charles River Laboratories, Inc.
    • 15.1.12. COREX LOGISTICS LIMITED
    • 15.1.13. Emsere B.V by Medicapital Holdco B.V.
    • 15.1.14. Eppendorf SE
    • 15.1.15. Evident Corporation by Olympus Corporation
    • 15.1.16. F. Hoffmann-La Roche Ltd.
    • 15.1.17. Fujifilm Group
    • 15.1.18. Hipro Biotechnology Co., Ltd.
    • 15.1.19. Hitachi, Ltd.
    • 15.1.20. HORIBA, Ltd.
    • 15.1.21. ICON PLC
    • 15.1.22. Immudex ApS
    • 15.1.23. Incyte Corporation
    • 15.1.24. IQVIA Inc.
    • 15.1.25. Johnson & Johnson Services, Inc.
    • 15.1.26. KLIFO A/S
    • 15.1.27. Labnet International
    • 15.1.28. Leica Microsystems GmbH by Danaher Corporation
    • 15.1.29. llumina, Inc.
    • 15.1.30. Lonza Group Ltd.
    • 15.1.31. Medline Industries, LP
    • 15.1.32. Merck KGaA
    • 15.1.33. Myonex, LLC
    • 15.1.34. Novo Nordisk A/S
    • 15.1.35. Nuvisan GmbH
    • 15.1.36. Parexel International Corporation
    • 15.1.37. Perceptive Informatics LLC and its affiliates, d/b/a Calyx
    • 15.1.38. PerkinElmer Inc. by Revvity, Inc.
    • 15.1.39. Pfizer Inc.
    • 15.1.40. Promega Corporation
    • 15.1.41. Recipharm AB
    • 15.1.42. Rubicon Research Pvt. Ltd.
    • 15.1.43. Sekisui Diagnostics Group
    • 15.1.44. Sharp Services, LLC
    • 15.1.45. Siemens Healthcare GmbH
    • 15.1.46. Smith & Nephew PLC
    • 15.1.47. Stryker Corporation
    • 15.1.48. Thermo Fisher Scientific Inc.
    • 15.1.49. Woodley Equipment Company Ltd.
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing